Funding Agency:
AIDS United

AIDS United, with support from Janssen Therapeutics, Division of Janssen Products, LP, is pleased to announce the opportunity for grant support through the Transgender Leadership Initiative. 

Transgender communities are critically affected by HIV and face unique challenges in HIV care. Because leadership from transgender communities is essential to addressing the dire HIV epidemic facing them, to improving transgender health outcomes, and to solidifying transgender power in our society, AIDS United is continuing to support the Transgender Leadership Initiative to identify and expand the leadership capabilities of transgender individuals in local communities. The Transgender Leadership Initiative will support the ability of transgender leaders to respond to HIV-related stigma, improve provider competency, and will bring to the table a vitally under-represented voice in the national response to HIV. Having transgender leaders at the helm ensures that transgender-specific needs stay at the forefront of these critical efforts, demonstrating the necessity of meaningful involvement of community members in HIV leadership. 

The goals of the Transgender Leadership Initiative are to:

  • Develop leaders in transgender communities to improve HIV service delivery for their peers;
  • Increase transgender leadership presence in HIV policy arenas; and
  • Create a cohort of connected transgender leaders who support each other and network to impact their communities for improved HIV outcomes.

AIDS United expects to award grants through this initiative by September 1, 2018. The average grant award will be $15,000; however, applicants are eligible to apply for grants up to $20,000. Grant periods must be between 6 months and 8 months. 

Letters of Inquiry are due by 5:00pm Eastern Time on May 31, 2018. 


Community Outreach and Engagement
Medical - Basic Science
Social Sciences

External Deadline

May 31, 2018